GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wakamoto Pharmaceutical Co Ltd (TSE:4512) » Definitions » Float Percentage Of Total Shares Outstanding

Wakamoto Pharmaceutical Co (TSE:4512) Float Percentage Of Total Shares Outstanding : 0.00% (As of Apr. 13, 2025)


View and export this data going back to 1949. Start your Free Trial

What is Wakamoto Pharmaceutical Co Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Wakamoto Pharmaceutical Co's float shares is 0.00 Mil. Wakamoto Pharmaceutical Co's total shares outstanding is 34.71 Mil. Wakamoto Pharmaceutical Co's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Wakamoto Pharmaceutical Co's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Wakamoto Pharmaceutical Co's Institutional Ownership is 0.12%.


Wakamoto Pharmaceutical Co Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Wakamoto Pharmaceutical Co's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/34.71
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wakamoto Pharmaceutical Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
2-2-2, Nihonbashi Honcho, Chuo-ku, Tokyo, JPN, 103-8330
Wakamoto Pharmaceutical Co Ltd is the pharmaceutical company based in Japan. It is engaged in the research and development, production and sale of ethical drugs and non-prescription drugs. The company specializes in therapeutic and diagnostic agents for ophthalmic disorders. It offers Strong Wakamoto, a gastrointestinal drug for digestion, the intestinal function controlling, and nutritional supply.

Wakamoto Pharmaceutical Co Headlines

No Headlines